According to our new research study on “Donor Blood Component Market Forecast to 2031 -Global Analysis - by Blood Component, Indication, Application, Age Group, and Geography,” the market is anticipated to grow from US$ 10.08 billion in 2024 and is projected to reach US$ 14.64 billion by 2031; it is expected to register a CAGR of 5.7% during 2025-2031.
Rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness are contributing to the growing donor blood component market size. However, the inconsistent voluntary donations hamper the donor blood component market growth. Further, rising demand for plasma-derived therapies are expected to bring in new donor blood component market trends in the coming years.
The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies.
However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.
Donor Blood Component Market Analysis
Emerging Market Demand to Provide Market Opportunities in Future
Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public-private alliances that have had on national blood systems.
Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.
According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.
The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.
Donor Blood Component Market Report Segmentation Analysis
Key segments that contributed to the derivation of the donor blood component market analysis are product, device type, application, age group, gender, and end user.
Donor Blood Component Market: Competitive Landscape and Key Developments
Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key companies operating in the donor blood component market.
The World Health Organization (WHO), the American Society of Plastic Surgeons, Health Resources and Services Administration, American Cancer Society, The Leukemia & Lymphoma Society, Health Canada, International Agency for Research on Cancer (IARC), Federal Statistical Office (Destatis), Macmillan Cancer Support data, National Health Commission (NHC), Indian Council of Medical Research-National Centre for Disease Informatics and Research (ICMR-NCDIR), Australian Institute of Health and Welfare, Australian Red Cross Lifeblood, GLOBOCAN are among the primary and secondary sources referred to while preparing the donor blood components market report.
Rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness are contributing to the growing donor blood component market size. However, the inconsistent voluntary donations hamper the donor blood component market growth. Further, rising demand for plasma-derived therapies are expected to bring in new donor blood component market trends in the coming years.
The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies.
However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.
Donor Blood Component Market Analysis
Emerging Market Demand to Provide Market Opportunities in Future
Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public-private alliances that have had on national blood systems.
Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.
According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.
The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.
Donor Blood Component Market Report Segmentation Analysis
Key segments that contributed to the derivation of the donor blood component market analysis are product, device type, application, age group, gender, and end user.
- Based on blood component, the donor blood components market is segmented into red blood cells, white blood cells, platelets, plasma, and others. The red blood cells segment held the largest share of the market in 2024.
- By indication, the donor blood components market is bifurcated into immunosuppression and oncology. The immunosuppression segment dominated the market in 2024.
- In terms of application, the donor blood components market is segmented into anemia management, thrombocytopenia treatment, coagulopathy correction, supportive care during chemotherapy, surgery, and others. The anemia management segment held the largest share of the market in 2024.
- By age group, the donor blood components market is bifurcated into adult and child. The adult segment dominated the market in 2024.
- As per end user, the donor blood components market is categorized into hospitals, oncology centers, transplant centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2024.
Donor Blood Component Market: Competitive Landscape and Key Developments
Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key companies operating in the donor blood component market.
The World Health Organization (WHO), the American Society of Plastic Surgeons, Health Resources and Services Administration, American Cancer Society, The Leukemia & Lymphoma Society, Health Canada, International Agency for Research on Cancer (IARC), Federal Statistical Office (Destatis), Macmillan Cancer Support data, National Health Commission (NHC), Indian Council of Medical Research-National Centre for Disease Informatics and Research (ICMR-NCDIR), Australian Institute of Health and Welfare, Australian Red Cross Lifeblood, GLOBOCAN are among the primary and secondary sources referred to while preparing the donor blood components market report.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the donor blood components market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the donor blood components market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Donor Blood Component Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. Donor Blood Component Market - Key Market Dynamics
5.1 Donor Blood Component Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Cancer and Immunosuppressive Diseases
5.2.2 Increasing Donor Awareness
5.3 Market Restraints
5.3.1 Inconsistent Voluntary Donations
5.4 Market Opportunities
5.4.1 Emerging Market Demand
5.5 Future Trends
5.5.1 Rising Demand for Plasma-Derived Therapies
5.6 Impact of Drivers and Restraints:
5.2 Market Drivers
5.2.1 Rising Prevalence of Cancer and Immunosuppressive Diseases
5.2.2 Increasing Donor Awareness
5.3 Market Restraints
5.3.1 Inconsistent Voluntary Donations
5.4 Market Opportunities
5.4.1 Emerging Market Demand
5.5 Future Trends
5.5.1 Rising Demand for Plasma-Derived Therapies
5.6 Impact of Drivers and Restraints:
6. Donor Blood Component Market - Global Market Analysis
6.1 Donor Blood Component Market Revenue (US$ Million), 2021-2031
6.2 Donor Blood Component Market Forecast Analysis
6.2 Donor Blood Component Market Forecast Analysis
7. Donor Blood Component Market Analysis - by Blood Component
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.1.1 Overview
7.1.2 Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
8. Donor Blood Component Market Analysis - by Indication
8.1 Immunosuppression
8.1.1 Overview
8.1.2 Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Oncology
8.2.1 Overview
8.2.2 Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1 Overview
8.1.2 Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Oncology
8.2.1 Overview
8.2.2 Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9. Donor Blood Component Market Analysis - by Application
9.1 Anemia management
9.1.1 Overview
9.1.2 Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Thrombocytopenia treatment
9.2.1 Overview
9.2.2 Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Coagulopathy Correction
9.3.1 Overview
9.3.2 Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Supportive care during chemotherapy
9.4.1 Overview
9.4.2 Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Surgery
9.5.1 Overview
9.5.2 Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1 Overview
9.1.2 Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Thrombocytopenia treatment
9.2.1 Overview
9.2.2 Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Coagulopathy Correction
9.3.1 Overview
9.3.2 Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Supportive care during chemotherapy
9.4.1 Overview
9.4.2 Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Surgery
9.5.1 Overview
9.5.2 Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
10. Donor Blood Component Market Analysis - by Age Group
10.1 Adult
10.1.1 Overview
10.1.2 Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Child
10.2.1 Overview
10.2.2 Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1 Overview
10.1.2 Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Child
10.2.1 Overview
10.2.2 Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11. Donor Blood Component Market Analysis - by End User
11.1 Hospitals
11.1.1 Overview
11.1.2 Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Oncology centers
11.2.1 Overview
11.2.2 Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Transplant centers
11.3.1 Overview
11.3.2 Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Ambulatory surgical centers
11.4.1 Overview
11.4.2 Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1 Overview
11.1.2 Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Oncology centers
11.2.1 Overview
11.2.2 Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Transplant centers
11.3.1 Overview
11.3.2 Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Ambulatory surgical centers
11.4.1 Overview
11.4.2 Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
12. Donor Blood Component Market - Geographical Analysis
12.1 North America
12.1.1 North America Donor Blood Component Market Overview
12.1.2 North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.1.2.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.1.2.2 North America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.1.2.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.1.2.3.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.1.2.3.2 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.1.2.4 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.1.2.5 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.1.2.6 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.1.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.1.3.1 United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.1.3.1.1 United States: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.1.2 United States: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.1.3 United States: Donor Blood Component Market Breakdown, by Indication
12.1.3.1.3.1 United States: Donor Blood Component Market Breakdown, by Immunosuppression
12.1.3.1.3.2 United States: Donor Blood Component Market Breakdown, by Oncology
12.1.3.1.4 United States: Donor Blood Component Market Breakdown, by Application
12.1.3.1.5 United States: Donor Blood Component Market Breakdown, by Age Group
12.1.3.1.6 United States: Donor Blood Component Market Breakdown, by End User
12.1.3.2 Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.1.3.2.1 Canada: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.2.2 Canada: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.2.3 Canada: Donor Blood Component Market Breakdown, by Indication
12.1.3.2.3.1 Canada: Donor Blood Component Market Breakdown,
12.1.3.2.3.2 Canada: Donor Blood Component Market Breakdown, by Oncology
12.1.3.2.4 Canada: Donor Blood Component Market Breakdown, by Application
12.1.3.2.5 Canada: Donor Blood Component Market Breakdown, by Age Group
12.1.3.2.6 Canada: Donor Blood Component Market Breakdown, by End User
12.1.3.3 Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.1.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.3.3 Mexico: Donor Blood Component Market Breakdown, by Indication
12.1.3.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Immunosuppression
12.1.3.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Oncology
12.1.3.3.4 Mexico: Donor Blood Component Market Breakdown, by Application
12.1.3.3.5 Mexico: Donor Blood Component Market Breakdown, by Age Group
12.1.3.3.6 Mexico: Donor Blood Component Market Breakdown, by End User
12.2 Europe
12.2.1 Europe Donor Blood Component Market Overview
12.2.2 Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.2.2.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.2.2.2 Europe: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.2.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.2.2.3.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.2.2.3.2 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.2.2.4 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.2.2.5 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.2.2.6 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.2.3.1 Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.1.1 Germany: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.1.2 Germany: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.1.3 Germany: Donor Blood Component Market Breakdown, by Indication
12.2.3.1.3.1 Germany: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.1.3.2 Germany: Donor Blood Component Market Breakdown, by Oncology
12.2.3.1.4 Germany: Donor Blood Component Market Breakdown, by Application
12.2.3.1.5 Germany: Donor Blood Component Market Breakdown, by Age Group
12.2.3.1.6 Germany: Donor Blood Component Market Breakdown, by End User
12.2.3.2 United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.2.1 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.2.2 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.2.3 United Kingdom: Donor Blood Component Market Breakdown, by Indication
12.2.3.2.3.1 United Kingdom: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.2.3.2 United Kingdom: Donor Blood Component Market Breakdown, by Oncology
12.2.3.2.4 United Kingdom: Donor Blood Component Market Breakdown, by Application
12.2.3.2.5 United Kingdom: Donor Blood Component Market Breakdown, by Age Group
12.2.3.2.6 United Kingdom: Donor Blood Component Market Breakdown, by End User
12.2.3.3 France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.3.1 France: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.3.2 France: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.3.3 France: Donor Blood Component Market Breakdown, by Indication
12.2.3.3.3.1 France: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.3.3.2 France: Donor Blood Component Market Breakdown, by Oncology
12.2.3.3.4 France: Donor Blood Component Market Breakdown, by Application
12.2.3.3.5 France: Donor Blood Component Market Breakdown, by Age Group
12.2.3.3.6 France: Donor Blood Component Market Breakdown, by End User
12.2.3.4 Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.4.1 Spain: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.4.2 Spain: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.4.3 Spain: Donor Blood Component Market Breakdown, by Indication
12.2.3.4.3.1 Spain: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.4.3.2 Spain: Donor Blood Component Market Breakdown, by Oncology
12.2.3.4.4 Spain: Donor Blood Component Market Breakdown, by Application
12.2.3.4.5 Spain: Donor Blood Component Market Breakdown, by Age Group
12.2.3.4.6 Spain: Donor Blood Component Market Breakdown, by End User
12.2.3.5 Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.5.1 Italy: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.5.2 Italy: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.5.3 Italy: Donor Blood Component Market Breakdown, by Indication
12.2.3.5.3.1 Italy: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.5.3.2 Italy: Donor Blood Component Market Breakdown, by Oncology
12.2.3.5.4 Italy: Donor Blood Component Market Breakdown, by Application
12.2.3.5.5 Italy: Donor Blood Component Market Breakdown, by Age Group
12.2.3.5.6 Italy: Donor Blood Component Market Breakdown, by End User
12.2.3.6 Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.6.1 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.6.2 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.6.3 Rest of Europe: Donor Blood Component Market Breakdown, by Indication
12.2.3.6.3.1 Rest of Europe: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.6.3.2 Rest of Europe: Donor Blood Component Market Breakdown, by Oncology
12.2.3.6.4 Rest of Europe: Donor Blood Component Market Breakdown, by Application
12.2.3.6.5 Rest of Europe: Donor Blood Component Market Breakdown, by Age Group
12.2.3.6.6 Rest of Europe: Donor Blood Component Market Breakdown, by End User
12.3 Asia Pacific
12.3.1 Asia Pacific Donor Blood Component Market Overview
12.3.2 Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.3.2.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.3.2.2 Asia Pacific: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.3.2.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.3.2.3.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.3.2.3.2 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.3.2.4 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.3.2.5 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.3.2.6 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.3.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.3.3.1 China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.1.1 China: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.1.2 China: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.1.3 China: Donor Blood Component Market Breakdown, by Indication
12.3.3.1.3.1 China: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.1.3.2 China: Donor Blood Component Market Breakdown, by Oncology
12.3.3.1.4 China: Donor Blood Component Market Breakdown, by Application
12.3.3.1.5 China: Donor Blood Component Market Breakdown, by Age Group
12.3.3.1.6 China: Donor Blood Component Market Breakdown, by End User
12.3.3.2 Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.2.1 Japan: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.2.2 Japan: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.2.3 Japan: Donor Blood Component Market Breakdown, by Indication
12.3.3.2.3.1 Japan: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.2.3.2 Japan: Donor Blood Component Market Breakdown, by Oncology
12.3.3.2.4 Japan: Donor Blood Component Market Breakdown, by Application
12.3.3.2.5 Japan: Donor Blood Component Market Breakdown, by Age Group
12.3.3.2.6 Japan: Donor Blood Component Market Breakdown, by End User
12.3.3.3 India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.3.1 India: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.3.2 India: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.3.3 India: Donor Blood Component Market Breakdown, by Indication
12.3.3.3.3.1 India: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.3.3.2 India: Donor Blood Component Market Breakdown, by Oncology
12.3.3.3.4 India: Donor Blood Component Market Breakdown, by Application
12.3.3.3.5 India: Donor Blood Component Market Breakdown, by Age Group
12.3.3.3.6 India: Donor Blood Component Market Breakdown, by End User
12.3.3.4 Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.4.1 Australia: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.4.2 Australia: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.4.3 Australia: Donor Blood Component Market Breakdown, by Indication
12.3.3.4.3.1 Australia: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.4.3.2 Australia: Donor Blood Component Market Breakdown, by Oncology
12.3.3.4.4 Australia: Donor Blood Component Market Breakdown, by Application
12.3.3.4.5 Australia: Donor Blood Component Market Breakdown, by Age Group
12.3.3.4.6 Australia: Donor Blood Component Market Breakdown, by End User
12.3.3.5 South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.5.1 South Korea: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.5.2 South Korea: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.5.3 South Korea: Donor Blood Component Market Breakdown, by Indication
12.3.3.5.3.1 South Korea: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.5.3.2 South Korea: Donor Blood Component Market Breakdown, by Oncology
12.3.3.5.4 South Korea: Donor Blood Component Market Breakdown, by Application
12.3.3.5.5 South Korea: Donor Blood Component Market Breakdown, by Age Group
12.3.3.5.6 South Korea: Donor Blood Component Market Breakdown, by End User
12.3.3.6 Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.6.1 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.6.2 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.6.3 Rest of APAC: Donor Blood Component Market Breakdown, by Indication
12.3.3.6.3.1 Rest of APAC: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.6.3.2 Rest of APAC: Donor Blood Component Market Breakdown, by Oncology
12.3.3.6.4 Rest of APAC: Donor Blood Component Market Breakdown, by Application
12.3.3.6.5 Rest of APAC: Donor Blood Component Market Breakdown, by Age Group
12.3.3.6.6 Rest of APAC: Donor Blood Component Market Breakdown, by End User
12.4 Middle East and Africa
12.4.1 Middle East and Africa Donor Blood Component Market Overview
12.4.2 Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.4.2.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.4.2.2 Middle East and Africa: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.4.2.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.4.2.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.4.2.3.2 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.4.2.4 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.4.2.5 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.4.2.6 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.4.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.4.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.4.3.2 Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.2.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.2.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.2.3 Saudi Arabia: Donor Blood Component Market Breakdown, by Indication
12.4.3.2.3.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.2.3.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Oncology
12.4.3.2.4 Saudi Arabia: Donor Blood Component Market Breakdown, by Application
12.4.3.2.5 Saudi Arabia: Donor Blood Component Market Breakdown, by Age Group
12.4.3.2.6 Saudi Arabia: Donor Blood Component Market Breakdown, by End User
12.4.3.3 South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.3.3 South Africa: Donor Blood Component Market Breakdown, by Indication
12.4.3.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Oncology
12.4.3.3.4 South Africa: Donor Blood Component Market Breakdown, by Application
12.4.3.3.5 South Africa: Donor Blood Component Market Breakdown, by Age Group
12.4.3.3.6 South Africa: Donor Blood Component Market Breakdown, by End User
12.4.3.4 United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.4.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.4.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.4.3 United Arab Emirates: Donor Blood Component Market Breakdown, by Indication
12.4.3.4.3.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.4.3.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Oncology
12.4.3.4.4 United Arab Emirates: Donor Blood Component Market Breakdown, by Application
12.4.3.4.5 United Arab Emirates: Donor Blood Component Market Breakdown, by Age Group
12.4.3.4.6 United Arab Emirates: Donor Blood Component Market Breakdown, by End User
12.4.3.5 Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.5.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.5.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.5.3 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Indication
12.4.3.5.3.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.5.3.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Oncology
12.4.3.5.4 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Application
12.4.3.5.5 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Age Group
12.4.3.5.6 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by End User
12.5 South and Central America
12.5.1 South and Central America Donor Blood Component Market Overview
12.5.2 South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.5.2.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.5.2.2 South and Central America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.5.2.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.5.2.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.5.2.3.2 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.5.2.4 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.5.2.5 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.5.2.6 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.5.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.5.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.5.3.2 Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.3.2.1 Brazil: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.2.2 Brazil: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.2.3 Brazil: Donor Blood Component Market Breakdown, by Indication
12.5.3.2.3.1 Brazil: Donor Blood Component Market Breakdown, by Immunosuppression
12.5.3.2.3.2 Brazil: Donor Blood Component Market Breakdown, by Oncology
12.5.3.2.4 Brazil: Donor Blood Component Market Breakdown, by Application
12.5.3.2.5 Brazil: Donor Blood Component Market Breakdown, by Age Group
12.5.3.2.6 Brazil: Donor Blood Component Market Breakdown, by End User
12.5.3.3 Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.3.3 Argentina: Donor Blood Component Market Breakdown, by Indication
12.5.3.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Immunosuppression
12.5.3.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Oncology
12.5.3.3.4 Argentina: Donor Blood Component Market Breakdown, by Application
12.5.3.3.5 Argentina: Donor Blood Component Market Breakdown, by Age Group
12.5.3.3.6 Argentina: Donor Blood Component Market Breakdown, by End User
12.5.3.4 Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.3.4.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.4.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.4.3 Rest of South and Central America: Donor Blood Component Market Breakdown, by Indication
12.5.3.4.3.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Immunosuppression
12.5.3.4.3.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Oncology
12.5.3.4.4 Rest of South and Central America: Donor Blood Component Market Breakdown, by Application
12.5.3.4.5 Rest of South and Central America: Donor Blood Component Market Breakdown, by Age Group
12.5.3.4.6 Rest of South and Central America: Donor Blood Component Market Breakdown, by End User
12.1.1 North America Donor Blood Component Market Overview
12.1.2 North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.1.2.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.1.2.2 North America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.1.2.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.1.2.3.1 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.1.2.3.2 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.1.2.4 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.1.2.5 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.1.2.6 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.1.3 North America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.1.3.1 United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.1.3.1.1 United States: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.1.2 United States: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.1.3 United States: Donor Blood Component Market Breakdown, by Indication
12.1.3.1.3.1 United States: Donor Blood Component Market Breakdown, by Immunosuppression
12.1.3.1.3.2 United States: Donor Blood Component Market Breakdown, by Oncology
12.1.3.1.4 United States: Donor Blood Component Market Breakdown, by Application
12.1.3.1.5 United States: Donor Blood Component Market Breakdown, by Age Group
12.1.3.1.6 United States: Donor Blood Component Market Breakdown, by End User
12.1.3.2 Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.1.3.2.1 Canada: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.2.2 Canada: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.2.3 Canada: Donor Blood Component Market Breakdown, by Indication
12.1.3.2.3.1 Canada: Donor Blood Component Market Breakdown,
12.1.3.2.3.2 Canada: Donor Blood Component Market Breakdown, by Oncology
12.1.3.2.4 Canada: Donor Blood Component Market Breakdown, by Application
12.1.3.2.5 Canada: Donor Blood Component Market Breakdown, by Age Group
12.1.3.2.6 Canada: Donor Blood Component Market Breakdown, by End User
12.1.3.3 Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.1.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Blood Component
12.1.3.3.3 Mexico: Donor Blood Component Market Breakdown, by Indication
12.1.3.3.3.1 Mexico: Donor Blood Component Market Breakdown, by Immunosuppression
12.1.3.3.3.2 Mexico: Donor Blood Component Market Breakdown, by Oncology
12.1.3.3.4 Mexico: Donor Blood Component Market Breakdown, by Application
12.1.3.3.5 Mexico: Donor Blood Component Market Breakdown, by Age Group
12.1.3.3.6 Mexico: Donor Blood Component Market Breakdown, by End User
12.2 Europe
12.2.1 Europe Donor Blood Component Market Overview
12.2.2 Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.2.2.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.2.2.2 Europe: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.2.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.2.2.3.1 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.2.2.3.2 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.2.2.4 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.2.2.5 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.2.2.6 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.2.3 Europe: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.2.3.1 Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.1.1 Germany: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.1.2 Germany: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.1.3 Germany: Donor Blood Component Market Breakdown, by Indication
12.2.3.1.3.1 Germany: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.1.3.2 Germany: Donor Blood Component Market Breakdown, by Oncology
12.2.3.1.4 Germany: Donor Blood Component Market Breakdown, by Application
12.2.3.1.5 Germany: Donor Blood Component Market Breakdown, by Age Group
12.2.3.1.6 Germany: Donor Blood Component Market Breakdown, by End User
12.2.3.2 United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.2.1 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.2.2 United Kingdom: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.2.3 United Kingdom: Donor Blood Component Market Breakdown, by Indication
12.2.3.2.3.1 United Kingdom: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.2.3.2 United Kingdom: Donor Blood Component Market Breakdown, by Oncology
12.2.3.2.4 United Kingdom: Donor Blood Component Market Breakdown, by Application
12.2.3.2.5 United Kingdom: Donor Blood Component Market Breakdown, by Age Group
12.2.3.2.6 United Kingdom: Donor Blood Component Market Breakdown, by End User
12.2.3.3 France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.3.1 France: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.3.2 France: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.3.3 France: Donor Blood Component Market Breakdown, by Indication
12.2.3.3.3.1 France: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.3.3.2 France: Donor Blood Component Market Breakdown, by Oncology
12.2.3.3.4 France: Donor Blood Component Market Breakdown, by Application
12.2.3.3.5 France: Donor Blood Component Market Breakdown, by Age Group
12.2.3.3.6 France: Donor Blood Component Market Breakdown, by End User
12.2.3.4 Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.4.1 Spain: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.4.2 Spain: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.4.3 Spain: Donor Blood Component Market Breakdown, by Indication
12.2.3.4.3.1 Spain: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.4.3.2 Spain: Donor Blood Component Market Breakdown, by Oncology
12.2.3.4.4 Spain: Donor Blood Component Market Breakdown, by Application
12.2.3.4.5 Spain: Donor Blood Component Market Breakdown, by Age Group
12.2.3.4.6 Spain: Donor Blood Component Market Breakdown, by End User
12.2.3.5 Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.5.1 Italy: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.5.2 Italy: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.5.3 Italy: Donor Blood Component Market Breakdown, by Indication
12.2.3.5.3.1 Italy: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.5.3.2 Italy: Donor Blood Component Market Breakdown, by Oncology
12.2.3.5.4 Italy: Donor Blood Component Market Breakdown, by Application
12.2.3.5.5 Italy: Donor Blood Component Market Breakdown, by Age Group
12.2.3.5.6 Italy: Donor Blood Component Market Breakdown, by End User
12.2.3.6 Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.3.6.1 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.6.2 Rest of Europe: Donor Blood Component Market Breakdown, by Blood Component
12.2.3.6.3 Rest of Europe: Donor Blood Component Market Breakdown, by Indication
12.2.3.6.3.1 Rest of Europe: Donor Blood Component Market Breakdown, by Immunosuppression
12.2.3.6.3.2 Rest of Europe: Donor Blood Component Market Breakdown, by Oncology
12.2.3.6.4 Rest of Europe: Donor Blood Component Market Breakdown, by Application
12.2.3.6.5 Rest of Europe: Donor Blood Component Market Breakdown, by Age Group
12.2.3.6.6 Rest of Europe: Donor Blood Component Market Breakdown, by End User
12.3 Asia Pacific
12.3.1 Asia Pacific Donor Blood Component Market Overview
12.3.2 Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.3.2.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.3.2.2 Asia Pacific: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.3.2.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.3.2.3.1 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.3.2.3.2 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.3.2.4 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.3.2.5 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.3.2.6 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.3.3 Asia Pacific: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.3.3.1 China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.1.1 China: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.1.2 China: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.1.3 China: Donor Blood Component Market Breakdown, by Indication
12.3.3.1.3.1 China: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.1.3.2 China: Donor Blood Component Market Breakdown, by Oncology
12.3.3.1.4 China: Donor Blood Component Market Breakdown, by Application
12.3.3.1.5 China: Donor Blood Component Market Breakdown, by Age Group
12.3.3.1.6 China: Donor Blood Component Market Breakdown, by End User
12.3.3.2 Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.2.1 Japan: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.2.2 Japan: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.2.3 Japan: Donor Blood Component Market Breakdown, by Indication
12.3.3.2.3.1 Japan: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.2.3.2 Japan: Donor Blood Component Market Breakdown, by Oncology
12.3.3.2.4 Japan: Donor Blood Component Market Breakdown, by Application
12.3.3.2.5 Japan: Donor Blood Component Market Breakdown, by Age Group
12.3.3.2.6 Japan: Donor Blood Component Market Breakdown, by End User
12.3.3.3 India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.3.1 India: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.3.2 India: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.3.3 India: Donor Blood Component Market Breakdown, by Indication
12.3.3.3.3.1 India: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.3.3.2 India: Donor Blood Component Market Breakdown, by Oncology
12.3.3.3.4 India: Donor Blood Component Market Breakdown, by Application
12.3.3.3.5 India: Donor Blood Component Market Breakdown, by Age Group
12.3.3.3.6 India: Donor Blood Component Market Breakdown, by End User
12.3.3.4 Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.4.1 Australia: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.4.2 Australia: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.4.3 Australia: Donor Blood Component Market Breakdown, by Indication
12.3.3.4.3.1 Australia: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.4.3.2 Australia: Donor Blood Component Market Breakdown, by Oncology
12.3.3.4.4 Australia: Donor Blood Component Market Breakdown, by Application
12.3.3.4.5 Australia: Donor Blood Component Market Breakdown, by Age Group
12.3.3.4.6 Australia: Donor Blood Component Market Breakdown, by End User
12.3.3.5 South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.5.1 South Korea: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.5.2 South Korea: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.5.3 South Korea: Donor Blood Component Market Breakdown, by Indication
12.3.3.5.3.1 South Korea: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.5.3.2 South Korea: Donor Blood Component Market Breakdown, by Oncology
12.3.3.5.4 South Korea: Donor Blood Component Market Breakdown, by Application
12.3.3.5.5 South Korea: Donor Blood Component Market Breakdown, by Age Group
12.3.3.5.6 South Korea: Donor Blood Component Market Breakdown, by End User
12.3.3.6 Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.3.6.1 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.6.2 Rest of APAC: Donor Blood Component Market Breakdown, by Blood Component
12.3.3.6.3 Rest of APAC: Donor Blood Component Market Breakdown, by Indication
12.3.3.6.3.1 Rest of APAC: Donor Blood Component Market Breakdown, by Immunosuppression
12.3.3.6.3.2 Rest of APAC: Donor Blood Component Market Breakdown, by Oncology
12.3.3.6.4 Rest of APAC: Donor Blood Component Market Breakdown, by Application
12.3.3.6.5 Rest of APAC: Donor Blood Component Market Breakdown, by Age Group
12.3.3.6.6 Rest of APAC: Donor Blood Component Market Breakdown, by End User
12.4 Middle East and Africa
12.4.1 Middle East and Africa Donor Blood Component Market Overview
12.4.2 Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.4.2.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.4.2.2 Middle East and Africa: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.4.2.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.4.2.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.4.2.3.2 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.4.2.4 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.4.2.5 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.4.2.6 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.4.3 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.4.3.1 Middle East and Africa: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.4.3.2 Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.2.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.2.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.2.3 Saudi Arabia: Donor Blood Component Market Breakdown, by Indication
12.4.3.2.3.1 Saudi Arabia: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.2.3.2 Saudi Arabia: Donor Blood Component Market Breakdown, by Oncology
12.4.3.2.4 Saudi Arabia: Donor Blood Component Market Breakdown, by Application
12.4.3.2.5 Saudi Arabia: Donor Blood Component Market Breakdown, by Age Group
12.4.3.2.6 Saudi Arabia: Donor Blood Component Market Breakdown, by End User
12.4.3.3 South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.3.3 South Africa: Donor Blood Component Market Breakdown, by Indication
12.4.3.3.3.1 South Africa: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.3.3.2 South Africa: Donor Blood Component Market Breakdown, by Oncology
12.4.3.3.4 South Africa: Donor Blood Component Market Breakdown, by Application
12.4.3.3.5 South Africa: Donor Blood Component Market Breakdown, by Age Group
12.4.3.3.6 South Africa: Donor Blood Component Market Breakdown, by End User
12.4.3.4 United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.4.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.4.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.4.3 United Arab Emirates: Donor Blood Component Market Breakdown, by Indication
12.4.3.4.3.1 United Arab Emirates: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.4.3.2 United Arab Emirates: Donor Blood Component Market Breakdown, by Oncology
12.4.3.4.4 United Arab Emirates: Donor Blood Component Market Breakdown, by Application
12.4.3.4.5 United Arab Emirates: Donor Blood Component Market Breakdown, by Age Group
12.4.3.4.6 United Arab Emirates: Donor Blood Component Market Breakdown, by End User
12.4.3.5 Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.3.5.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.5.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Blood Component
12.4.3.5.3 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Indication
12.4.3.5.3.1 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Immunosuppression
12.4.3.5.3.2 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Oncology
12.4.3.5.4 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Application
12.4.3.5.5 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by Age Group
12.4.3.5.6 Rest of Middle East and Africa: Donor Blood Component Market Breakdown, by End User
12.5 South and Central America
12.5.1 South and Central America Donor Blood Component Market Overview
12.5.2 South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
12.5.2.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Blood Component
12.5.2.2 South and Central America: Donor Blood Component Market - Volume and Forecast Analysis - by Blood Component
12.5.2.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Indication
12.5.2.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Immunosuppression
12.5.2.3.2 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Oncology
12.5.2.4 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Application
12.5.2.5 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Age Group
12.5.2.6 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by End User
12.5.3 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.5.3.1 South and Central America: Donor Blood Component Market - Revenue and Forecast Analysis - by Country
12.5.3.2 Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.3.2.1 Brazil: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.2.2 Brazil: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.2.3 Brazil: Donor Blood Component Market Breakdown, by Indication
12.5.3.2.3.1 Brazil: Donor Blood Component Market Breakdown, by Immunosuppression
12.5.3.2.3.2 Brazil: Donor Blood Component Market Breakdown, by Oncology
12.5.3.2.4 Brazil: Donor Blood Component Market Breakdown, by Application
12.5.3.2.5 Brazil: Donor Blood Component Market Breakdown, by Age Group
12.5.3.2.6 Brazil: Donor Blood Component Market Breakdown, by End User
12.5.3.3 Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.3.3 Argentina: Donor Blood Component Market Breakdown, by Indication
12.5.3.3.3.1 Argentina: Donor Blood Component Market Breakdown, by Immunosuppression
12.5.3.3.3.2 Argentina: Donor Blood Component Market Breakdown, by Oncology
12.5.3.3.4 Argentina: Donor Blood Component Market Breakdown, by Application
12.5.3.3.5 Argentina: Donor Blood Component Market Breakdown, by Age Group
12.5.3.3.6 Argentina: Donor Blood Component Market Breakdown, by End User
12.5.3.4 Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.3.4.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.4.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Blood Component
12.5.3.4.3 Rest of South and Central America: Donor Blood Component Market Breakdown, by Indication
12.5.3.4.3.1 Rest of South and Central America: Donor Blood Component Market Breakdown, by Immunosuppression
12.5.3.4.3.2 Rest of South and Central America: Donor Blood Component Market Breakdown, by Oncology
12.5.3.4.4 Rest of South and Central America: Donor Blood Component Market Breakdown, by Application
12.5.3.4.5 Rest of South and Central America: Donor Blood Component Market Breakdown, by Age Group
12.5.3.4.6 Rest of South and Central America: Donor Blood Component Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Donor Blood Component Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
13.2 Growth Strategies in the Donor Blood Component Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. COMPANY PROFILES
14.1 Roswell Park Comprehensive Cancer Center
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Policlinico of Milan
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.3 Vitalant
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MD Anderson Cancer Center.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.5 The Johns Hopkins Hospital
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.6 The Royal Marsden
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.7 Gustave Roussy
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.8 Peter MacCallum Cancer Centre
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.9 Tata Memorial Hospital
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Memorial Sloan Kettering Cancer Center
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Policlinico of Milan
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.3 Vitalant
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MD Anderson Cancer Center.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.5 The Johns Hopkins Hospital
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.6 The Royal Marsden
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.7 Gustave Roussy
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.8 Peter MacCallum Cancer Centre
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.9 Tata Memorial Hospital
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Memorial Sloan Kettering Cancer Center
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Donor Blood Component Market Segmentation
Table 2. Average Selling Price Per Unit (US$) of Blood Components, 2024
Table 3. Global Disease Prevalence of 5 Key Diseases, 2024
Table 4. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 5. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 6. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
Table 7. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
Table 8. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 9. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 10. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 11. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 12. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 13. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 14. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 15. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 16. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 17. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 18. North America: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 19. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 20. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 21. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 22. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 23. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 24. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 25. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 26. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 27. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 28. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 29. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 30. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 31. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 32. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 33. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 34. United States: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 35. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 36. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 37. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 38. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 39. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 40. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 41. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 42. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 43. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 44. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 45. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 46. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 47. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 48. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 49. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 50. Canada: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 51. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 52. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 53. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 54. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 55. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 56. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 57. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 58. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 59. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 60. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 61. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 62. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 63. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 64. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 65. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 66. Mexico: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 67. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 68. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 69. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 70. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 71. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 72. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 73. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 74. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 75. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 76. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 77. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 78. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 79. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 80. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 81. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 82. Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 83. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 84. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 85. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 86. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 87. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 88. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 89. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 90. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 91. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 92. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 93. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 94. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 95. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 96. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 97. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 98. Germany: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 99. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 100. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 101. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 102. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 103. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 104. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 105. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 106. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 107. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 108. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 109. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 110. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 111. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 112. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 113. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 114. United Kingdom: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 115. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 116. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 117. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 118. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 119. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 120. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 121. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 122. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 123. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 124. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 125. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 126. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 127. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 128. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 129. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 130. France: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 131. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 132. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 133. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 134. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 135. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 136. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 137. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 138. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 139. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 140. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 141. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 142. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 143. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 144. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 145. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 146. Spain: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 147. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 148. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 149. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 150. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 151. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 152. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 153. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 154. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 155. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 156. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 157. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 158. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 159. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 160. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 161. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 162. Italy: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 163. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 164. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 165. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 166. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 167. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 168. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 169. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 170. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 171. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 172. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 173. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 174. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 175. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 176. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 177. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 178. Rest of Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 179. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 180. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 181. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 182. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 183. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 184. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 185. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 186. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 187. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 188. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 189. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 190. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 191. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 192. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 193. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 194. Asia Pacific: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 195. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 196. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 197. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 198. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 199. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 200. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 201. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 202. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 203. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 204. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 205. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 206. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 207. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 208. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 209. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 210. China: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 211. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 212. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 213. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 214. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 215. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 216. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 217. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 218. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 219. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 220. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 221. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 222. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 223. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 224. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 225. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 226. Japan: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 227. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 228. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 229. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 230. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 231. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 232. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 233. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 234. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 235. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 236. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 237. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 238. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 239. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 240. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 241. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 242. India: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 243. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 244. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 245. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 246. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 247. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 248. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 249. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 250. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 251. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 252. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 253. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 254. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 255. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 256. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 257. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 258. Australia: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 259. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 260. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 261. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 262. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 263. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 264. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 265. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 266. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 267. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 268. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 269. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 270. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 271. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 272. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 273. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 274. South Korea: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 275. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 276. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 277. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 278. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 279. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 280. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 281. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 282. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 283. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 284. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 285. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 286. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 287. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 288. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 289. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 290. Rest of APAC: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 291. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 292. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 293. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 294. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 295. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 296. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 297. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 298. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 299. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 300. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 301. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 302. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 303. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 304. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 305. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 306. Middle East and Africa: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 307. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 2. Average Selling Price Per Unit (US$) of Blood Components, 2024
Table 3. Global Disease Prevalence of 5 Key Diseases, 2024
Table 4. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 5. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 6. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
Table 7. Donor Blood Component Market - Volume, 2021-2024 (Units Million) - by Blood Component
Table 8. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 9. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 10. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 11. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 12. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 13. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 14. Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 15. Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 16. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 17. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 18. North America: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 19. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 20. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 21. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 22. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 23. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 24. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 25. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 26. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 27. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 28. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 29. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 30. North America: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 31. North America: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 32. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 33. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 34. United States: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 35. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 36. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 37. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 38. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 39. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 40. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 41. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 42. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 43. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 44. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 45. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 46. United States: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 47. United States: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 48. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 49. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 50. Canada: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 51. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 52. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 53. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 54. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 55. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 56. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 57. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 58. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 59. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 60. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 61. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 62. Canada: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 63. Canada: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 64. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 65. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 66. Mexico: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 67. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 68. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 69. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 70. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 71. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 72. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 73. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 74. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 75. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 76. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 77. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 78. Mexico: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 79. Mexico: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 80. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 81. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 82. Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 83. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 84. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 85. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 86. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 87. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 88. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 89. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 90. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 91. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 92. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 93. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 94. Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 95. Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 96. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 97. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 98. Germany: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 99. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 100. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 101. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 102. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 103. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 104. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 105. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 106. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 107. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 108. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 109. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 110. Germany: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 111. Germany: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 112. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 113. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 114. United Kingdom: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 115. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 116. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 117. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 118. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 119. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 120. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 121. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 122. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 123. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 124. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 125. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 126. United Kingdom: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 127. United Kingdom: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 128. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 129. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 130. France: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 131. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 132. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 133. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 134. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 135. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 136. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 137. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 138. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 139. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 140. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 141. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 142. France: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 143. France: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 144. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 145. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 146. Spain: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 147. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 148. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 149. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 150. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 151. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 152. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 153. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 154. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 155. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 156. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 157. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 158. Spain: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 159. Spain: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 160. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 161. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 162. Italy: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 163. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 164. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 165. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 166. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 167. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 168. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 169. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 170. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 171. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 172. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 173. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 174. Italy: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 175. Italy: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 176. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 177. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 178. Rest of Europe: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 179. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 180. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 181. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 182. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 183. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 184. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 185. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 186. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 187. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 188. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 189. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 190. Rest of Europe: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 191. Rest of Europe: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 192. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 193. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 194. Asia Pacific: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 195. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 196. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 197. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 198. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 199. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 200. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 201. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 202. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 203. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 204. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 205. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 206. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 207. Asia Pacific: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 208. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 209. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 210. China: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 211. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 212. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 213. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 214. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 215. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 216. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 217. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 218. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 219. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 220. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 221. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 222. China: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 223. China: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 224. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 225. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 226. Japan: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 227. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 228. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 229. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 230. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 231. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 232. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 233. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 234. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 235. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 236. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 237. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 238. Japan: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 239. Japan: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 240. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 241. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 242. India: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 243. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 244. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 245. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 246. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 247. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 248. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 249. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 250. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 251. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 252. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 253. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 254. India: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 255. India: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 256. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 257. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 258. Australia: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 259. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 260. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 261. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 262. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 263. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 264. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 265. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 266. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 267. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 268. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 269. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 270. Australia: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 271. Australia: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 272. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 273. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 274. South Korea: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 275. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 276. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 277. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 278. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 279. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 280. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 281. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 282. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 283. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 284. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 285. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 286. South Korea: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 287. South Korea: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 288. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 289. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 290. Rest of APAC: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 291. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 292. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Indication
Table 293. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
Table 294. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Immunosuppression
Table 295. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Immunosuppression
Table 296. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Oncology
Table 297. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Oncology
Table 298. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 299. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 300. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Age Group
Table 301. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Age Group
Table 302. Rest of APAC: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 303. Rest of APAC: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 304. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2024 (US$ Million) - by Blood Component
Table 305. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
Table 306. Middle East and Africa: Donor Blood Component Market - Volume, 2021-2024 (Unit Million) - by Blood Component
Table 307. Middle East and Africa: Donor Blood Component Market - Revenue Forecast, 2025-2031 (US$ Million) - by Blood Component
LIST OF FIGURES
Figure 1. Donor Blood Component Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Donor Blood Component Market Revenue (US$ Million), 2021-2031
Figure 5. Donor Blood Component Market Share (%) - by Blood Component (2024 and 2031)
Figure 6. Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Donor Blood Component Market Share (%) - by Indication (2024 and 2031)
Figure 12. Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Donor Blood Component Market Share (%) - by Application (2024 and 2031)
Figure 15. Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Donor Blood Component Market Share (%) - by Age Group (2024 and 2031)
Figure 22. Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Donor Blood Component Market Share (%) - by End User (2024 and 2031)
Figure 25. Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 31. North America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 32. United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 33. Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 34. Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 36. Europe: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 37. Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 38. United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 39. France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 40. Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 41. Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 42. Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 43. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 44. Asia Pacific: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 46. Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 48. Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 49. South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 50. Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 51. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 52. Middle East and Africa: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 53. Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 54. South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 55. United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 56. Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 57. South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 58. South and Central America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 59. Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 60. Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 61. Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 62. Growth Strategies in the Donor Blood Component Market
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Donor Blood Component Market Revenue (US$ Million), 2021-2031
Figure 5. Donor Blood Component Market Share (%) - by Blood Component (2024 and 2031)
Figure 6. Red Blood Cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. White blood cells: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Platelets: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Plasma: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Donor Blood Component Market Share (%) - by Indication (2024 and 2031)
Figure 12. Immunosuppression: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Oncology: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Donor Blood Component Market Share (%) - by Application (2024 and 2031)
Figure 15. Anemia management: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Thrombocytopenia treatment: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Coagulopathy Correction: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Supportive care during chemotherapy: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Surgery: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Donor Blood Component Market Share (%) - by Age Group (2024 and 2031)
Figure 22. Adult: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Child: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Donor Blood Component Market Share (%) - by End User (2024 and 2031)
Figure 25. Hospitals: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. Oncology centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Transplant centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Ambulatory surgical centers: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Others: Donor Blood Component Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. North America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 31. North America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 32. United States: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 33. Canada: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 34. Mexico: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Europe: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 36. Europe: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 37. Germany: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 38. United Kingdom: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 39. France: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 40. Spain: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 41. Italy: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 42. Rest of Europe: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 43. Asia Pacific: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 44. Asia Pacific: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. China: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 46. Japan: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. India: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 48. Australia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 49. South Korea: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 50. Rest of APAC: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 51. Middle East and Africa: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 52. Middle East and Africa: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 53. Saudi Arabia: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 54. South Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 55. United Arab Emirates: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 56. Rest of Middle East and Africa: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 57. South and Central America: Donor Blood Component Market - Revenue, 2021-2031 (US$ Million)
Figure 58. South and Central America: Donor Blood Component Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 59. Brazil: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 60. Argentina: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 61. Rest of South and Central America: Donor Blood Component Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 62. Growth Strategies in the Donor Blood Component Market
Companies Mentioned
The List of Companies in the Donor Blood Components Market include:- Mayo Clinic
- Cleveland Clinic
- Johns Hopkins Medicine
- Memorial Sloan Kettering Cancer Center
- Singapore General Hospital
- King’s College Hospital
- Charité University Hospital
- Royal Melbourne Hospital
- St. Michael’s Hospital
- Tokyo Medical University Hospital
- Massachusetts General Hospital
- UCLA Medical Center
- NewYork-Presbyterian Hospital
- Karolinska University Hospital
- The Royal Free Hospital
- Zentrum für Transfusionsmedizin (ZTM)
- Asan Medical Center
- Apollo Hospitals
- Cecil Memorial Hospital
- King Fahd Military Medical Complex
- Bumrungrad International Hospital
- Hospital das Clínicas
- Aga Khan University Hospital
- University of California, San Francisco (UCSF) Medical Center
- Peking Union Medical College Hospital
- The Aga Khan University Hospital (Nairobi)
- Fuda Cancer Hospital
- St. Thomas' Hospital
- Beijing Tiantan Hospital
- Cairo University Hospital
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 342 |
Published | July 2025 |
Forecast Period | 2024 - 2031 |
Estimated Market Value in 2024 | 10.08 Billion |
Forecasted Market Value by 2031 | 14.64 Billion |
Compound Annual Growth Rate | 5.7% |
Regions Covered | Global |
No. of Companies Mentioned | 31 |